Literature DB >> 16311305

Medicine. Cancer-suppressing enzyme adds a link to type 2 diabetes.

Jean Marx.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16311305     DOI: 10.1126/science.310.5752.1259a

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


× No keyword cloud information.
  3 in total

1.  Anti-cancer effect of metformin by suppressing signaling pathway of HER2 and HER3 in tamoxifen-resistant breast cancer cells.

Authors:  Jinkyoung Kim; Jiyun Lee; Chungyeul Kim; Jinhyuk Choi; Aeree Kim
Journal:  Tumour Biol       Date:  2015-11-18

2.  Tissue microarrays characterise the clinical significance of a VEGF-A protein expression signature in gastrointestinal stromal tumours.

Authors:  M Salto-Tellez; M E Nga; H C Han; A S-C Wong; C K Lee; D Anuar; S S Ng; M Ho; A Wee; Y H Chan; R Soong
Journal:  Br J Cancer       Date:  2007-02-13       Impact factor: 7.640

3.  Anticancer effect of metformin on estrogen receptor-positive and tamoxifen-resistant breast cancer cell lines.

Authors:  Jinkyoung Kim; Jiyun Lee; Soon Young Jang; Chungyeul Kim; Yoojin Choi; Aeree Kim
Journal:  Oncol Rep       Date:  2016-03-11       Impact factor: 3.906

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.